Chemical Compound

Desethyl Candesartan Cilexetil

CAS Registry Number 869631-11-8
Back to search Request a Quote
Desethyl Candesartan Cilexetil chemical structure
Primary Record

Desethyl Candesartan Cilexetil

In stock
7,943 g
Purity
98.5 %
CAS
869631-11-8

Compound Identifiers & Properties

CAS
869631-11-8
PubChem CID
46783540
SMILES
CC(OC(=O)C1=C2C(=CC=C1)NC(=O)N2CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)OC(=O)OC6CCCCC6
Canonical SMILES
CC(OC(=O)OC1CCCCC1)OC(=O)c1cccc2[nH]c(=O)n(Cc3ccc(-c4ccccc4-c4nn[nH]n4)cc3)c12

Names & Synonyms

  • Desethyl Candesartan Cilexetil
  • O-Desethyl Candesartan Cilexetil
  • 869631-11-8
  • JC6R5VA63B
  • Candesartan Cilexetil EP impurity B
  • RefChem:1083177
  • UNII-JC6R5VA63B
  • SCHEMBL8169172
  • SCHEMBL12181757
  • SCHEMBL30007561
  • Candesartan cilexetil Related Compound B
  • Candesartan cilexetil impurity B [EP]
  • FT-0665945
  • G87494
  • Candesartan cilexetil specified impurity B [EP]
  • A1-01747
  • CANDESARTAN CILEXETIL IMPURITY B [EP IMPURITY]
  • Q27281429
  • 1-cyclohexyloxycarbonyloxyethyl 2-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-benzimidazole-4-carboxylate
  • CANDESARTAN CILEXETIL RELATED COMPOUND B [USP-RS]
  • (1RS)-1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-oxo-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2,3-dihydro-1H-benzimidazole-4-carboxylate
  • 1H-Benzimidazole-4-carboxylic acid, 2,3-dihydro-2-oxo-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • 1H-Benzimidazole-4-carboxylic acid, 2,3-dihydro-2-oxo-3-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • 2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
  • (+/-)-1-(Cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H -tetrazol-5-yl)biphenyl-4-yl)methyl(-2-oxobenzimidazole-7-carboxylate
  • (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Oxo-3-[[2'-(1H-tetrazol-5-yl-)-biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate
  • (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl-2-oxo-3-[[2'-(1H-tetrazol-5-yl) biphenyl- 4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate
  • 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate
  • 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2,3-dihydro-2-oxo-3-[[2 inverted exclamation marka-(2H-tetrazol-5-yl)[1,1 inverted exclamation marka-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylate
  • O-Desethyl Candesartan Cilexetil; (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Oxo-3-[[2'-(1H-tetrazol-5-yl-)-biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate; 1H-Benzimidazole-4-carboxylic acid, 2,3-dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1H-Benzimidazole-4-carboxylic acid, 2,3-dihydro-2-oxo-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester (9CI); Candesartan Cilexetil Imp. B (EP)